Navigation Links
Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
Date:5/23/2013

conclusions that with a continuous monitoring solution we can care for more of our patients on medical/surgical floors, and keep them safer with better outcomes."

In the second poster, a significant decrease in RRT calls from 10.5 to 5.6 per 1000 patients was demonstrated after intervention. Though the number of code blue events did not change significantly, the outcomes improved with intervention. The percentage of patients that stayed in the unit, after coding, increased from 18.8% to 55.6%. Transfers to the ICU and death decreased during intervention by a factor of 3.38 and 1.31 respectively.

"The need for continuous monitoring of vital signs, to detect early warning signs of deteriorating patients, was very clear for all participants in the conference. I am happy and proud they recognized the research on the EarlySense technology as a novel solution that allows nurses and physicians to do exactly that," said Dr. Shinar.

About EarlySense

EarlySense has brought to market an innovative technology designed to advance proactive patient care and enable clinicians to achieve better patient outcomes, by assisting in preventing adverse events from occurring through their early identification, in the form of falls, pressure ulcers and/or patient deterioration. The company's flagship product, the EarlySense System, is a continuous, contact-free, patient safety monitoring solution that monitors and documents a patient's vital signs and movement using a sensor that is placed underneath a bed mattress. There are no leads or cuffs to connect to the patient who has complete freedom of movement and is not burdened by any cumbersome attachments. The system was initially designed to monitor non-ICU 'lower risk' patients on medical surgical floors who are usually monitored by nursing staff approximately once every four hours. The system is currently installed at hospitals and rehabilitation centers in the USA and Euro
'/>"/>

SOURCE EarlySense
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013
2. New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR
3. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
4. Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
5. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
6. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
7. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
8. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
9. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
10. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 On Tuesday, July 1, ... suit in the 116 th Judicial District ... against RegenLab USA, LLC ("Defendant") for ... Relationships through false and misleading actions, fraud, ... Disparagement through libel, disparagement, defamation, misrepresentation, and ...
(Date:7/23/2014)... July 23, 2014  RT Oncology Services Corporation today ... join its board of directors. Mr. Mundie is currently ... he works on strategic projects within the company and ... chief research and strategy officer. ... RainTree, said, "Craig is a visionary technology executive. His ...
(Date:7/23/2014)... /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation Strategies ... market entry results in $5.4 billion in lost savings ... by economic consulting firm Matrix Global Advisors ... Required by the Food and Drug Administration ... are intended to improve drug safety by ensuring that ...
Breaking Medicine Technology:Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2
(Date:7/23/2014)... July 23, 2014 The European Vitamins ... Europe with analysis and projection of revenue. The market ... million in 2012 to $1,202.08 million by 2018, at ... Browse through the TOC of the European Vitamins Market ... provided. This also provides a glimpse of the segmentation ...
(Date:7/23/2014)... European Bio fertilizers Market Report defines and segments the ... of revenue. The bio fertilizers market in Europe is ... 2012 to $4,582.2 million by 2017, at a CAGR ... the TOC of the European Bio fertilizers Market report, ... , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , The bio fertilizers ...
(Date:7/23/2014)... (July 23, 2014) Statins, a class of drugs ... patient,s risk of developing Barrett,s esophagus, according to a ... , the official journal of the American Gastroenterological Association. ... with statin use. , "Patients who received statins had ... Barrett,s esophagus compared to non-users," said study author Hashem ...
(Date:7/23/2014)... to a new market research report of "Semiconductor (Silicon) ... IP), Design Architecture (Hard IP, Soft IP), Processor Type ... & Analysis to 2013 - 2020", the semiconductor (silicon) ... of 12.6% from 2014 to 2020 and reach $5.63 ... data tables with 60 figures spread through 337 pages ...
(Date:7/23/2014)... identified three genetic changes linked to an increased risk ... investigators, was published online July 20 in Nature ... the most common malignancies among women worldwide, most studies ... focused on women of European ancestry. , Given the ... Asian women and those of European ancestry, the investigators ...
Breaking Medicine News(10 mins):Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6Health News:Vanderbilt-led study identifies genes linked to breast cancer in East Asian women 2
... has found that alcohol does not kill off brain ... Queensland Brain Institute director Professor Perry Bartlett, the notion ... function similar to a napalm bomb strike, is erroneous. ... the world's top neuroscientists, claims that there is no ...
... Anderson Cancer Center have found in pre-clinical trials that ... in pancreatic cancer that shrinks or eradicates tumours, inhibits ... ,"This vehicle, or vector, is so targeted and ... used for therapy and perhaps for imaging," notes senior ...
... Residents in the United Kingdom would have to consider ... want to enjoy a pollution-free and greener future, a ... has said. ,According to the report, the ... operated cars and avoiding affordable flights. ...
... stroke patients practise daily tasks with impaired limbs, are ... Administration has approved a new robotic device called the Myomo ... arms. It is to hit the market shortly. ... weak electrical activity in patients arm muscles and providing just ...
... a new gene mutation that is associated with frontotemporal ... known as Prick's disease . ,Frontotemporal ... brain that control behaviour and language. Language problems, personality ... ,Unlike Alzheimer's disease, this Frontotemporal dementia does ...
... many of the genetic bits and pieces that drive ... disadvantages to humans or other animals. ,Nicholas ... Medicine said that the Hopkins experiments demonstrate that one ... DNA repeat elements that make up over 40 percent ...
Cached Medicine News:Health News:Gene Therapy Eradicates Pancreatic Cancer in Mice 2Health News:Brits Need to Change Lifestyle to Have a Greener Future: Report 2Health News:FDA Approve S Robotic Device to Help Stroke Patients 2Health News:FDA Approve S Robotic Device to Help Stroke Patients 3Health News:FDA Approve S Robotic Device to Help Stroke Patients 4Health News:Scientists Identify New Genetic Mutation Behind Common Dementia 2Health News:Completely Neutral Evolutionary Changes Helped Shape Our Genome 2
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
... The SleepStyle 200 series offers a ... CPAP models. The design delivers therapy ... Performance features promote results in commercial ... The strongest differentiator in the SleepStyle ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
The S7 Lightweight offers the comfort and reliability of the award-winning S7 series in a convenient, affordable device....
Medicine Products: